CVS stops sale of Zantac heartburn drugs over cancer concerns

CVS has halted sales of popular heartburn treatment Zantac and the store generic version after warnings by U.S. health regulators.

COOKIE DOUGH RECALL OVER POSSIBLE NUT ALLERGENS 

CVS is the latest retailer to pull the heartburn tablets from store shelves. Earlier this month, the U.S. Food and Drug Administration warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.

In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications such as Pepcid.

CLICK HERE FOR THE ALL-NEW FOXBUSINESS.COM

Some manufacturers of the drug have stopped distribution. Health officials say concerned patients should consult their doctor.